Matthew Herper on Muck Rack

Matthew Herper

Verified
  • Senior Writer, Medicine and Editorial Director, Events, STAT
New York
As seen in: STAT, UOL, Business Insider, Forbes, Scribd, CNBC, PBS News Hour - Health, PBS NewsHour, Boston.com, Scientific American, Flipboard and
Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Signal: MattHerper.92

Get in touch with Matthew

Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways

|
By Adam Feuerstein , Matthew Herper , Angus Chen , Katherine MacPhail
| Flipboard
At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. …
Open in Who Shared Issue with article?

A standing ovation for RevMed, and caution for Akeso

|
By Adam Feuerstein , Matthew Herper , Katherine MacPhail, Angus Chen 
| Flipboard
Security 11 hours ago Random Standard Wi-Fi Routers Can Scan Your Body to Identify Exactly Who You Are, Alarming New Research Finds futurism.com - Joe Wilkins • 11h "With this hardware making its way into millions of homes, the privacy concerns are severe." If you were paranoid about digital tracking before, you … Social Sciences 1 day ago The Trump Administration Is Done With Social Science The Atlantic - By Hana Kiros • 1d The National Science Foundation division that covers social,...
Open in Who Shared Issue with article?

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

|
By Matthew Herper 
| The Boston Globe
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70 percent, according to newly released data. Though results appear to have missed a key statistical bar, the companies said they would still be approaching regulators in hopes the vaccine would be approved.
Open in Who Shared Issue with article?
See all 1,351 licensed articles (2,264 Total)

Actions

Share this page

Get in touch with Matthew

Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified